Norris Medicines Ltd.
BSE: 524414 | Sector: Others |
NSE: N.A. | ISIN Code: INE744C01029 |
BSE 00:00 | 26 Feb | 6.00 |
0 (0.00%) |
OPEN
6.00 |
HIGH
6.00 |
LOW
6.00 |
NSE 05:30 | 01 Jan | Norris Medicines Ltd |
OPEN | 6.00 |
PREVIOUS CLOSE | 6.00 |
VOLUME | 40 |
52-Week high | 6.30 |
52-Week low | 2.45 |
P/E | |
Mkt Cap.(Rs cr) | 6 |
Buy Price | 6.00 |
Buy Qty | 984.00 |
Sell Price | 6.00 |
Sell Qty | 16.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Norris Medicines Ltd. (NORRISMEDICINES) - Half Yearly Result
Particulars (![]() |
Sep '20 | Mar '20 | Sep '19 | Mar '19 | Sep '18 |
Net Sales/Income From Operations | 5.01 | 3.12 | 4.72 | 9.53 | 6.78 |
Other Income | 0.02 | 0.08 | 0.01 | -0.01 | 0.01 |
Total Income | 5.03 | 3.20 | 4.73 | 9.52 | 6.79 |
Total Expenditure | 5.83 | 4.42 | 5.58 | 9.53 | 7.35 |
Operating Profit | -0.80 | -1.22 | -0.85 | -0.01 | -0.56 |
Interest | 0.39 | 0.51 | 0.37 | 0.37 | 0.36 |
Gross Profit | -1.19 | -1.74 | -1.22 | -0.38 | -0.92 |
Depreciation | 0.36 | 0.37 | 0.36 | 0.36 | 0.35 |
PBT | -1.55 | -2.11 | -1.57 | -0.73 | -1.27 |
Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit/(Loss) | -1.55 | -1.27 | -1.57 | -0.40 | -1.27 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | -1.55 | -1.27 | -1.57 | -0.40 | -1.27 |
Equity Share Capital | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | -1.55 | 0.00 | -1.57 | 0.00 | -1.27 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Norris Medicines:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices